#news #biotech Forty Seven lines up Roche as second partner for CD47 cancer immunotherapy

Biotechnology, Pharma and Biopharma News РResearch РScience РLifescience ://Biotech-Biopharma-Pharma: Forty Seven lines up Roche as second partner for CD47 cancer immunotherapy .Forty Seven has added Roche to its partner list for CD47-targeted immuno-oncology candidate, with Roche’s Genentech unit agreeing to sponsor two trials of the antibody in combination with its PD-L1 inhibitor Tecentriq.

from FierceBiotech: Biotech http://ift.tt/2EA37rc